Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months-Reference-Cited by-同舟云学术

Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months

Published:2021-10-26 Issue:8 Volume:28 Page:
ISSN:1195-1982
Container-title:Journal of Travel Medicine
language:en
Short-container-title:

Author:

Ponticelli Domenico¹,Antonazzo Ippazio C²,Caci Grazia³,Vitale Andrea¹,Della Ragione Giovanni¹,Romano Maria L¹,Borrelli Mario¹,Schiavone Beniamino¹,Polosa Riccardo⁴⁵,Ferrara Pietro²⁶^ORCID

Affiliation:

1. Pineta Grande Hospital, Castel Volturno (Caserta), Italy

2. Center for Public Health Research, University of Milan—Bicocca, Monza, Italy

3. Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

4. Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Italy

5. Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy

6. IRCCS MultiMedica, Sesto San Giovanni (Milan), Italy

Abstract

This sero-survey describes the level and time-trend of antibodies elicited by BNT162b2 COVID-19 vaccine up to 6 months. A strong seroconversion was seen at 30-day serology, with persistence of anti-SARS-CoV-2 S-RBD IgG through 6 months from vaccination. However, the level of vaccine-induced antibodies started to decrease from the second month.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://academic.oup.com/jtm/advance-article-pdf/doi/10.1093/jtm/taab173/41166639/taab173.pdf

Reference8 articles.

1. Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19;Doria-Rose;N Engl J Med,2021

2. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine;Tai;Cell Mol Immunol,2020

3. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up;Ponticelli;Intern Emerg Med,2021

4. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine;Krammer;N Engl J Med,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection;Nature Communications;2024-02-26

2. Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers;Journal of Clinical Medicine;2023-04-28

3. Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study;Vaccines;2023-01-22

4. An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines;Vaccines;2022-12-26

5. Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States;Frontiers in Public Health;2022-11-22